SD-6 is an Orally Active hAChE/hBChE Inhibitor for Alzheimer’s Disease Research
Alzheimer's disease (AD) is the most common form of dementia. The cholinesterase enzymes (ChEs), i.e., AChE and butyrylcholine esterase (BChE) inhibitors, are the most promising therapeutic strategy. Firstly, it can…